ATE368226T1 - Verfahren zum untersuchen von krebs aggressivität mit polymerisierte aktin bestimmung - Google Patents

Verfahren zum untersuchen von krebs aggressivität mit polymerisierte aktin bestimmung

Info

Publication number
ATE368226T1
ATE368226T1 AT03799634T AT03799634T ATE368226T1 AT E368226 T1 ATE368226 T1 AT E368226T1 AT 03799634 T AT03799634 T AT 03799634T AT 03799634 T AT03799634 T AT 03799634T AT E368226 T1 ATE368226 T1 AT E368226T1
Authority
AT
Austria
Prior art keywords
polymerized actin
studying cancer
aggressivity
determination
actin determination
Prior art date
Application number
AT03799634T
Other languages
English (en)
Inventor
Christelle Pragnon
Valerie Polard
Frederic Subra
Christian Auclair
Original Assignee
Bioalliance Pharma
Ecole Norm Superieure Cachan
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioalliance Pharma, Ecole Norm Superieure Cachan, Centre Nat Rech Scient filed Critical Bioalliance Pharma
Application granted granted Critical
Publication of ATE368226T1 publication Critical patent/ATE368226T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/4712Muscle proteins, e.g. myosin, actin, protein
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT03799634T 2002-12-19 2003-12-18 Verfahren zum untersuchen von krebs aggressivität mit polymerisierte aktin bestimmung ATE368226T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0216188A FR2849203B1 (fr) 2002-12-19 2002-12-19 Methode d'analyse de l'agressivite tumorale de cellules cancereuses comprenant la mesure de la quantite d'actine polymerisee a l'etat stationnaire

Publications (1)

Publication Number Publication Date
ATE368226T1 true ATE368226T1 (de) 2007-08-15

Family

ID=32406206

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03799634T ATE368226T1 (de) 2002-12-19 2003-12-18 Verfahren zum untersuchen von krebs aggressivität mit polymerisierte aktin bestimmung

Country Status (11)

Country Link
US (1) US7491505B2 (de)
EP (1) EP1573334B1 (de)
JP (1) JP4602771B2 (de)
AT (1) ATE368226T1 (de)
AU (1) AU2003299352A1 (de)
CA (1) CA2511076A1 (de)
DE (1) DE60315189T2 (de)
ES (1) ES2291744T3 (de)
FR (1) FR2849203B1 (de)
PT (1) PT1573334E (de)
WO (1) WO2004057337A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2437063B1 (de) * 2010-08-10 2014-05-07 Commissariat à l'Energie Atomique et aux Energies Alternatives Vorrichtungen und Verfahren zur Steuerung von Aktinfilamentenwachstum und -organisation unter Verwendung mikrostrukturierter Kernbildungsstellen
WO2020193735A1 (en) * 2019-03-26 2020-10-01 Fast Bt Ug Detection and quantification of molecular species

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5851786A (en) * 1995-09-27 1998-12-22 National Jewish Center For Immunology And Respiratory Medicine Product and process to regulate actin polymerization
ES2263218T3 (es) * 1997-09-04 2006-12-01 The Board Of Trustees Of The Leland Stanford Junior University Ensayos para detectar moduladores de la funcion del citoesqueleto.
AU2088801A (en) * 1999-12-10 2001-06-18 Dana-Farber Cancer Institute, Inc. Metastasis genes and uses thereof
FR2806805A1 (fr) * 2000-03-22 2001-09-28 Centre Nat Rech Scient SEQUENCE PEPTIDIQUES COMPRENANT UN OU PLUSIEURS MOTIFS DE LIAISON AUX PROTEINES DE LA FAMILLE Ena/VASP, ET LEURS UTILISATIONS

Also Published As

Publication number Publication date
EP1573334A1 (de) 2005-09-14
AU2003299352A8 (en) 2004-07-14
WO2004057337A1 (fr) 2004-07-08
FR2849203A1 (fr) 2004-06-25
JP2006511217A (ja) 2006-04-06
PT1573334E (pt) 2007-11-05
AU2003299352A1 (en) 2004-07-14
DE60315189D1 (de) 2007-09-06
ES2291744T3 (es) 2008-03-01
DE60315189T2 (de) 2008-04-10
FR2849203B1 (fr) 2005-02-18
EP1573334B1 (de) 2007-07-25
CA2511076A1 (fr) 2004-07-08
JP4602771B2 (ja) 2010-12-22
US7491505B2 (en) 2009-02-17
US20060166289A1 (en) 2006-07-27

Similar Documents

Publication Publication Date Title
DE60325482D1 (de) Verfahren zur charakterisierung von biomolekülen mittels resultat-gesteuerter strategie
ATE378404T1 (de) Verfahren zum nachweis von oxidativem stress sowie kit zur durchführung davon
IL252832A0 (en) Use of biomarkers for detecting ovarian cancer
ATE353455T1 (de) Verfahren zur sequenzanalyse
ATE554106T1 (de) Antikörper für onkogene stämme von hpv und verfahren zu deren verwendung
SE0004221L (sv) Metod och anordning för talanalys
GB2430740A (en) System and method for tracking and quatitating chemical entites
ATE408200T1 (de) Verfahren und system zur durchführung von prüfungen in einer einrichtung und einrichtung
ATE466283T1 (de) Zentrifugalvorrichtung und verfahren zur durchführung von bindungsversuchen
DE60103428D1 (de) Identifizierung von zellen während kinetischer versuchsreihen
ATE416384T1 (de) Verfahren und kit zum quantitativen und/oder qualitativen nachweis von komponenten in einer probe
WO2005012901A3 (en) Method for measuring aromatase activity
ATE368226T1 (de) Verfahren zum untersuchen von krebs aggressivität mit polymerisierte aktin bestimmung
NO20024755D0 (no) Metode
DE60323677D1 (de) Verfahren zur bestimmung des wiederauftretens von prostata krebs
ATE394676T1 (de) Verbindungen und verfahren zur diagnose von prostatakrebs
NO20035695L (no) Fremgangsmate for utforelse av objektbasert konnektivitetsanalyse i 3D seismiske datavolumer
DE60327776D1 (de) Sonden zum nachweis von tumorzellen
BR0010259A (pt) Método para caracterização de células, kit, e, aparelho para executar análise de par‰metro único ou de múltiplos par‰metros em uma suspensão de células
TW200643894A (en) Music editing methods and related devices
ATE437372T1 (de) Verfahren zur messung von proinsulin und c-peptid sowie kit dafür
ATE374990T1 (de) Verfahren zum synthetisieren von sprache
ATE466285T1 (de) Diagnose von leberzirrhose mittels eines für menschliches protoonkogenes protein spezifischen antikörpers
ATE320602T1 (de) Verfahren und testsatz zur evaluierung der metastasierungstendenz von tumoren
DK1382691T3 (da) Fremgangsmåde til isolering af 20S-proteasomet samt fremgangsmåde til identifikation af inhibitorer af 20S- og 26S-proteasomet

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1573334

Country of ref document: EP